KRT6C
Keratin, type II cytoskeletal 6C
Also known as: K2C6C_HUMAN, KRT6E
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48668
- Gene
- KRT6C
- Ensembl
- ENSG00000170465
- Chromosome
- 12
- Canonical length
- 564 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Intermediate filaments
OverviewNCBI Gene
Keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into epithelial keratins and hair keratins. The type II keratins are clustered in a region of chromosome 12q13. [provided by RefSeq, Jul 2009]
Canonical amino-acid sequenceUniProt
564 residues, UniProt reviewed canonical sequence.
>P48668|KRT6C
1 MASTSTTIRS HSSSRRGFSA NSARLPGVSR SGFSSISVSR SRGSGGLGGA CGGAGFGSRS
61 LYGLGGSKRI SIGGGSCAIS GGYGSRAGGS YGFGGAGSGF GFGGGAGIGF GLGGGAGLAG
121 GFGGPGFPVC PPGGIQEVTV NQSLLTPLNL QIDPAIQRVR AEEREQIKTL NNKFASFIDK
181 VRFLEQQNKV LDTKWTLLQE QGTKTVRQNL EPLFEQYINN LRRQLDSIVG ERGRLDSELR
241 NMQDLVEDLK NKYEDEINKR TAAENEFVTL KKDVDAAYMN KVELQAKADT LTDEINFLRA
301 LYDAELSQMQ THISDTSVVL SMDNNRNLDL DSIIAEVKAQ YEEIAQRSRA EAESWYQTKY
361 EELQVTAGRH GDDLRNTKQE IAEINRMIQR LRSEIDHVKK QCASLQAAIA DAEQRGEMAL
421 KDAKNKLEGL EDALQKAKQD LARLLKEYQE LMNVKLALDV EIATYRKLLE GEECRLNGEG
481 VGQVNVSVVQ STISSGYGGA SGVGSGLGLG GGSSYSYGSG LGIGGGFSSS SGRAIGGGLS
541 SVGGGSSTIK YTTTSSSSRK SYKHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KRT6C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 792 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 792 nTPM
- cervix: 483 nTPM
- vagina: 322 nTPM
- salivary gland: 148 nTPM
- skin: 22 nTPM
- tonsil: 8.9 nTPM
Single-cell type
- esophageal apical cells: 5,611 nCPM
- esophageal suprabasal cells: 5,141 nCPM
- suprabasal keratinocytes: 1,606 nCPM
- esophageal basal cells: 314 nCPM
- basal keratinocytes: 115 nCPM
- mast cells: 37 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KRT6C.
Disease | AllUniProt
Conditions KRT6C is implicated in, by any mechanism.
- Palmoplantar keratoderma, non-epidermolytic, focal or diffuse (PPKNEFD) MIM:615735
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 200 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Focal palmoplantar keratoderma
- Palmoplantar keratoderma, nonepidermolytic, focal or diffuse
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.19
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KRT6C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KRT6C as an antibody target. Whether an autoantibody or antibody against KRT6C could matter depends on whether native KRT6C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KRT6C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KRT6C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...